カテゴリ： , , MarketLine

The Bank Of East Asia, Limited

◆英語タイトル：The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3470
◆発行会社（調査会社）：MarketLine
◆発行日：2019
◆ページ数：57
◆レポート言語：
◆レポート形式：PDF
◆納品方法：E
◆対象地域：
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

The Bank Of East Asia, Limited – Strategy, SWOT and Corporate Finance Report
Summary

The Bank Of East Asia, Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

The Bank of East Asia, Limited (BEA) offers a range of banking, insurance, and related financial products and services to individual and corporate clients. Its product portfolio includes savings and current accounts, mortgage loans, consumer loans, credit cards, commercial term loans, foreign currency deposits accounts, and life and non-life insurance solutions. It also provides services such as deposit services, private banking, wealth protection trust services, portfolio management services, foreign exchange, and trade financing services. The bank has a presence in Hong Kong, China, Singapore, Malaysia, the UK, Macau, Taiwan, and the US. BEA is headquartered in Hong Kong City, Hong Kong.

Scope

- Detailed information on The Bank Of East Asia, Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Bank Of East Asia, Limited in the form of a SWOT analysis
- An in-depth view of the business model of The Bank Of East Asia, Limited including a breakdown and examination of key business segments
- Intelligence on The Bank Of East Asia, Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Bank Of East Asia, Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Bank Of East Asia, Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Bank Of East Asia, Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Bank Of East Asia, Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
The Bank of East Asia, Limited: Company Overview
The Bank of East Asia, Limited: Overview and Key Facts
The Bank of East Asia, Limited: Overview
The Bank of East Asia, Limited: Key Facts
The Bank of East Asia, Limited: Key Employees
The Bank of East Asia, Limited: Key Employee Biographies
The Bank of East Asia, Limited: Major Products and Services
The Bank of East Asia, Limited: Company History
The Bank of East Asia, Limited: Management Statement
The Bank of East Asia, Limited: Locations and Subsidiaries
The Bank of East Asia, Limited: Key Competitors
The Bank of East Asia, Limited: Company Analysis
The Bank of East Asia, Limited: Business Description
The Bank of East Asia, Limited: SWOT Analysis
The Bank of East Asia, Limited: SWOT Overview
The Bank of East Asia, Limited: Strengths
The Bank of East Asia, Limited: Weaknesses
The Bank of East Asia, Limited: Opportunities
The Bank of East Asia, Limited: Threats
The Bank of East Asia, Limited: Corporate Financial Deals Activity
The Bank of East Asia, Limited: Financial Deals Overview
The Bank of East Asia, Limited: Targets and Partners
The Bank of East Asia, Limited: Top Deals 2015 – 2019YTD*
The Bank of East Asia, Limited: Advisors
The Bank of East Asia, Limited: Top Financial Advisors
The Bank of East Asia, Limited: Mergers and Acquisitions
The Bank of East Asia, Limited: Capital Raising
The Bank of East Asia, Limited: Partnership
The Bank of East Asia, Limited: Divestments
The Bank of East Asia, Limited: Private Equity and Ownership
The Bank of East Asia, Limited: Recent Developments
The Bank of East Asia, Limited: News and Events Summary
The Bank of East Asia, Limited: Business Expansion
The Bank of East Asia, Limited: Contracts
The Bank of East Asia, Limited: Corporate Governance
The Bank of East Asia, Limited: Financial Deals
The Bank of East Asia, Limited: Financial Performance
The Bank of East Asia, Limited: Market Developments
The Bank of East Asia, Limited: Regulatory and Legal Events
The Bank of East Asia, Limited: Research & Development
The Bank of East Asia, Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: The Bank of East Asia, Limited: Key Facts
Table 2: The Bank of East Asia, Limited: Key Employees
Table 3: The Bank of East Asia, Limited: Company History
Table 4: The Bank of East Asia, Limited: Locations and Subsidiaries
Table 5: The Bank of East Asia, Limited: Key Competitors
Table 6: The Bank of East Asia, Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: The Bank of East Asia, Limited: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: The Bank of East Asia, Limited: Targets and Partners
Table 9: The Bank of East Asia, Limited: Top Deals 2015 - 2019YTD*
Table 10: The Bank of East Asia, Limited: Financial Advisor Ranking by Value (US$m)
Table 11: The Bank of East Asia, Limited: M&A Volume and Value Trend (2015 - YTD*2019)
Table 12: The Bank of East Asia, Limited: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 13: The Bank of East Asia, Limited: Capital Raising by Deal Type (2015 - YTD*2019)
Table 14: The Bank of East Asia, Limited: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 15: The Bank of East Asia, Limited: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 16: The Bank of East Asia, Limited: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 17: The Bank of East Asia, Limited: Divestments by Geography (2015 - YTD*2019)
Table 18: The Bank of East Asia, Limited: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 19: The Bank of East Asia, Limited: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 20: The Bank of East Asia, Limited: News and Events Summary
Table 21: The Bank of East Asia, Limited: Business Expansion
Table 22: The Bank of East Asia, Limited: Contracts
Table 23: The Bank of East Asia, Limited: Corporate Governance
Table 24: The Bank of East Asia, Limited: Financial Deals
Table 25: The Bank of East Asia, Limited: Financial Performance
Table 26: The Bank of East Asia, Limited: Market Developments
Table 27: The Bank of East Asia, Limited: Regulatory and Legal Events
Table 28: The Bank of East Asia, Limited: Research & Development
Table 29: The Bank of East Asia, Limited: Strategy and Operations

★海外企業調査レポート[The Bank Of East Asia, Limited]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • NanoString Technologies Inc (NSTG)：企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Venture Corporation Limited (V03)：企業の財務・戦略的SWOT分析
    Venture Corporation Limited (V03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Institute for Translational Vaccinology：製薬・医療：M&Aディール及び事業提携情報
    Summary Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel …
  • Mars Incorporated：企業の戦略的SWOT分析
    Mars Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Eastman Chemical Company：企業のM&A・事業提携・投資動向
    Eastman Chemical Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eastman Chemical Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • ValiRx Plc (VAL)：企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. ValiRx uses GeneICE technology, which enables silen …
  • Uniper SE (UN01)：企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • HeartWare International Inc-医療機器分野：企業M&A・提携分析
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that co …
  • NTT DOCOMO Inc：企業の戦略・SWOT・財務分析
    NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report Summary NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Eagle Plains Resources Ltd (EPL)：企業の財務・戦略的SWOT分析
    Summary Eagle Plains Resources Ltd (Eagle Plains) operates as a mining and mineral exploration and mine development company that offers mineral resources. The company offers acquisition, exploration, mining, operations, management, production, and development gold, base metals, rare earth elements, …
  • Metropolitan Health Networks Inc-製薬・医療分野：企業M&A・提携分析
    Summary Metropolitan Health Networks Inc (MHN) a subsidiary of Humana Inc is a healthcare organization that offers primary care services. The organization operates through a network of doctors, nurses and specialists for seniors insured through Medicare. It provides service through provider service …
  • PharmaZell GmbH：企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Reliance Worldwide Corporation Ltd (RWC)：企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • CohBar Inc (COB.U)：企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Institut Pasteur-製薬・医療分野：企業M&A・提携分析
    Summary Institut Pasteur is a non-profit foundation that provides research, health services and education. The institute offers research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structural biology an …
  • U.P. Hotels Ltd.：企業の戦略・SWOT・財務情報
    U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Emirates Group：企業の戦略・SWOT・財務情報
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Irving Oil Ltd：企業の戦略的SWOT分析
    Irving Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CloudFlare Inc (NET)：企業の財務・戦略的SWOT分析
    CloudFlare Inc (NET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Synthetic Biologics Inc (SYN)：企業の財務・戦略的SWOT分析
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆